⌘K
Loading ticker…
As of 2026-08-24, NRX Pharmaceuticals, Inc. Common Stock (NRXP) has a 3-month relative strength percentile of 62 within the TickerStance CS+ADRC universe (~5,000 tickers). Its Power rating (absolute 1–99) is 63. The current market Stance is 47.8 (Neutral). Sector: Healthcare, ranked 3 of 11. Average daily range 9.5%, relative volume 0.71×. TickerStance reports observed regime conditions across the full CS+ADRC universe; band assignment reflects current breadth, momentum, and macro inputs computed at the daily close. Percentile ranks run from 1 (weakest) to 99 (strongest) relative to all universe members on the same date.
Relative strength across horizons plus the leadership score.
Accumulation rating, relative volume, U/D ratio, breakout-day proof.
Daily range, ATR, beta, and the math for a 1-ADR stop.
Diluted EPS, last 8 quarters. Loss makers are judged by progress toward breakeven.
YoY sales growth, last 8 quarters. Sales must back the earnings story.
Operating margin unavailable
YoY common shares outstanding. Down = buyback tailwind. Up > 2% = dilution flag.
Reported figures from SEC filings. No analyst estimates or forward guidance.
NRXP is held by 3 ETFs as of Mar 2026. Top owner: VTI at 0.00% weight, $2M notional. Top 3 carry $3M.
Held by 4 ETFs · $3M across latest filings · largest weight 4.42% (PSIL).
Top 3 by value, from SEC N-PORT-P filings dated Mar 2026.
| ETF | Weight | Value | Δ |
|---|---|---|---|
| VTIVanguard Total Stock Market ETF | 0.00% | $2M | — |
| PSIL | 4.42% | $896K | — |
| VXFVanguard Extended Market ETF | 0.00% | $691K | — |
As filed in N-PORT — quarterly holdings with up to ~60-day publication lag. Not live positioning.
Attention is elevated versus its own recent norm without the relative strength to match — the loud-but-lagging pattern. Worth a skeptical eye; not a short signal.
Measures how unusual this name’s public attention is against its own 90-day history — a surprise reading, not a ranking of how watched it is versus other stocks. Intel, not a signal.
News
Related searches
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | NRXP Jan avg: 0.15% median: -7.08% win: 50% σ: 27.74% n: 4 2022-04-12 → 2026-07-31 | NRXP Feb avg: -13.01% median: -12.13% win: 0% σ: 9.00% n: 4 2022-04-12 → 2026-07-31 | NRXP Mar avg: 0.22% median: 2.41% win: 50% σ: 29.13% n: 4 2022-04-12 → 2026-07-31 | NRXP Apr avg: -8.45% median: -11.82% win: 40% σ: 32.60% n: 5 2022-04-12 → 2026-07-31 | NRXP May avg: 15.37% median: 24.53% win: 80% σ: 46.26% n: 5 2022-04-12 → 2026-07-31 | NRXP Jun avg: -8.72% median: -7.47% win: 40% σ: 25.14% n: 5 2022-04-12 → 2026-07-31 | NRXP Jul avg: -6.75% median: -17.48% win: 20% σ: 22.65% n: 5 2022-04-12 → 2026-07-31 | NRXP Aug avg: -18.62% median: -18.19% win: 0% σ: 4.36% n: 4 2022-04-12 → 2026-07-31 (current) | NRXP Sep avg: 8.64% median: 2.11% win: 50% σ: 25.24% n: 4 2022-04-12 → 2026-07-31 | NRXP Oct avg: 2.37% median: 1.70% win: 50% σ: 19.04% n: 4 2022-04-12 → 2026-07-31 | NRXP Nov avg: 14.57% median: 0.73% win: 50% σ: 43.56% n: 4 2022-04-12 → 2026-07-31 | NRXP Dec avg: 22.34% median: 22.17% win: 75% σ: 38.27% n: 4 2022-04-12 → 2026-07-31 |